CELLforCURE by Seqens

CELLforCURE by Seqens is pleased to announce its participation in the Innovative Therapies Days 𝗶𝗻 𝗕𝗲𝘀𝗮𝗻𝗰̧𝗼𝗻 𝗼𝗻 𝗼𝗰𝘁𝗼𝗯𝗲𝗿 𝟭𝟬𝘁𝗵 & 𝟭𝟭𝘁𝗵, 𝟮𝟬𝟮𝟰. 📍 Visit our booth #4 to discover our expertise in autologous and allogeneic #CAR-T cell therapies. Discover our One Stop Shop solution and our offering of on-demand GMP manufacturing lines, precisely tailored to your process and product needs, from Phase I trials to full commercial production. #cellandgenetherapies #celltherapy #CART #cells #CDMO #development #manufacturing #ATMPs #AdvancedTherapies #Cellforcure #Seqens #Ouscienceforyourfuture

CELLforCURE by Seqens is thrilled to announce its participation in the - IV Convegno Italiano sulle Terapie Avanzate e Radiofarmaci - in Rimini from September 25 to 27!   This pivotal event will gather leading experts and innovators in the field of advanced therapies and radiopharmaceuticals. Join us as we explore the cutting-edge advancements shaping the future of medical research. Our very own Alexandre Fouassier will be available during the conference for insightful discussions about ATMP production. Don't miss this opportunity to connect and collaborate! #AdvancedTherapies #Radiopharmaceuticals #Innovation #MedicalResearch #ConvegnoRimini2024 Looking forward to seeing you there! 

[CAR-TCR Summit] 📢 CELLforCURE by Seqens is at CAR-TCR Summit Series. We were thrilled to participate in Workshop C: "𝐌𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠 𝐚𝐭 𝐭𝐡𝐞 𝐂𝐀𝐑-𝐓𝐂𝐑 𝐒𝐮𝐦𝐦𝐢𝐭 𝐒𝐞𝐫𝐢𝐞𝐬" in Boston! Our CCO, Marc-Olivier Mignon, presented on "Leveraging Real-World Experience to Optimize Cell Therapy Manufacturing."   He delved into these key topics: ➡️The Uniqueness of CD-19 CAR-T Large-Scale Manufacturing experience ➡️Key Technical Success Factors for CDMOs and Manufacturers to move from early phases to phase III and commercial manufacturing ➡️Navigating the Learning Curve for Smooth Transitions   Join our team at booth #73 to discuss your projects, from clinical to commercial production. Our experts are ready to assist you.   To learn more visit our website: cellandgene.seqens.com #Seqens #ourscienceforyourfuture #CELLforCURE #CARTherapy #CellTherapy #GMP #Manufacturing #CARTCR #CGT

We are ready for the 9th Annual CAR-TCR Summit!   Join us on September 17 at 9.00 AM for an insightful discussion on optimizing and accelerating CAR-T cell therapy manufacturing. Discover how real-life experience can enhance large-scale manufacturing services and learn how CELLforCURE by Seqens's expertise can elevate your process. Don't miss it!   For more info, come and meet us at booth #73   #GMPmanufacturing #cart #cartcells #celltherapy #ourscienceforyourfuture

Dive into Cell & Gene Therapies, from concept to commercialization, with fully customizable GMP manufacturing lines! Leveraging advanced technologies, extensive capabilities, and large-scale capacity, we provide a seamless journey from early-stage development to commercial manufacturing for a wide range of cell therapies all within our fully integrated 'One-Stop Shop' facility. For more information, contact us : cellforcure@seqens.com   #cellandgenetherapies #celltherapy #cells #GMPmanufacturing #CGT #Ourscienceforyourfuture

🎥 We are happy to share with you all the new video showcasing SEQENS activities and the group's ambitions for the future. To watch the video 👉 https://lnkd.in/dT9CnQ5n #Seqens #Ourscienceforyourfuture #Corporatevideo

We are excited to announce that CELLforCURE is now a proud member of MabDesign! 🎉 Joining this prestigious network is a significant milestone for us as we continue our mission to advance the manufacturing of innovative cell and gene therapies. We look forward to collaborating with MabDesign, sharing knowledge, and contributing to the growth and success of the biopharmaceutical sector. Together, we can drive forward the future of therapeutic solutions ! #CELLforCURE #MabDesign #Biotechnology #CellTherapy #GeneTherapy #Innovation #Healthcare #CDMO

We're delighted to continue our serie of portraits of the members of the CELLforCURE by Seqens Scientific Advisory Board. This week, we're honored to introduce you to Olivier Danos a thought leader in the field of gene therapy.   Olivier Danos is Executive Vice President and Chief Scientific Officer of REGENXBIO Inc. a gene therapy company. His early research in molecular genetics, cell biology and virology led to the development of innovative gene therapy technologies. Over the past 35 years, Olivier has held senior positions in the biopharmaceutical industry, notably at Kadmon, Biogen and Généthon. He has also worked at major research institutions such as University College of London, Necker Hosiptal , Centre National de la Recherche Scientifique(CNRS) and Institut Pasteur. His expertise and enlightened leadership have been essential in advancing gene therapy and helping to improve the lives of many patients. We are proud to have Olivier on our Scientific Advisory Board at CELLforCURE by Seqens.   Stay tuned to learn more about our exceptional members in the coming weeks. #CellforCure #Seqens #ScientificCouncil #Portrait #Cell&GeneTherapy #MedicalResearch #Ourscienceforyourfuture

📣 The CELLforCURE by Seqens team is excited to participate in the Global Cell & Gene Therapy Summit in Boston to discuss how CELLorCURE can accelerate your journey from bench to bedside with GMP manufacturing. This summit showcases the latest research progress in cell & gene therapy and explores opportunities for further enhancements in the availability and productivity of these therapies. 🤝 By fostering collaboration and knowledge exchange, the summit aims to advance the field of cell and gene therapy. Want to learn more ? Visit 👉 https://lnkd.in/dqqhRPSS

𝗧𝗼𝗱𝗮𝘆 𝗶𝘀 𝗮 𝘀𝗽𝗲𝗰𝗶𝗮𝗹 𝗱𝗮𝘆 𝗳𝗼𝗿 𝘁𝗵𝗲 𝗕𝗶𝗼𝗽𝗿𝗼𝗱𝘂𝗰𝘁𝗶𝗼𝗻 𝗼𝗳 𝗕𝗶𝗼𝗺𝗲𝗱𝗶𝗰𝗮𝗺𝗲𝗻𝘁𝘀 𝘀𝗲𝗰𝘁𝗼𝗿! We are thrilled to share that Marc-Olivier Mignon, CCO of CELLforCURE by Seqens, has the pleasure to participate in the National Bioproduction of Biomedicaments Day organized by France BioLead, of which SEQENS is now a proud member[Negre, Helene] The aim of this day is to shine a spotlight on the entire Bioproduction of Biomedicaments Sector. All day long, a series of events and initiatives are organized all over France by the actors of the ecosystem. CellforCure by Seqens’s presentation is an great opportunity to reiterate Seqens’s ambitions to support the development of Cell & Gene Therapies in front of the major players in the Health Bioproduction sector in the Région Ile de France. 🚀 Let’s continue to innovate and push the boundaries of #science to improve further the health and well-being of all. Together, we are stronger! #JNBB #Bioproduction #Biomedicaments #CellForCure #GeneTherapy #CellTherapy #Innovation #FranceBiolead #Ourscienceforyourfuture